Clinical Trial Update: Safety of Pioglitazone for Hematoma Resolution In Intracerebral Hemorrhage [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the safety of pioglitazone for hematoma resolution in intracerebral hemorrhage has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intracerebral Hemorrhage

Drugs mentioned

• Actos (Pioglitazone)

Snippet

Sponsor: The University of Texas Health Science Center, Houston | Conditions: Intracerebral Hemorrhage | Phase 2 | Status: COMPLETED